REPRIEVE-Logo-WebREPRIEVE-Logo-WebREPRIEVE-Logo-WebREPRIEVE-Logo-Web
  • About REPRIEVE
    • Our Story
    • Publications
    • In the News
    • Study FAQ
    • REPRIEVE @ CROI 2023
  • Meet Our Team
    • Clinical Coordinating Center (CCC)
    • Data Coordinating Center (DCC)
    • REPRIEVE Site Teams
    • Community Scientific Subcommittee (CSS)
    • REPRIEVE Community Advisory Board (CAB)
    • National Institutes of Health
  • For Participants
    • Meet REPRIEVE Participants
    • My Matters Blog
    • Participant Newsletter
    • REPRIEVE Community Forum
    • Recursos en Español
      • Preguntas Más Frecuentes
      • Mapa de Centros de Investigación Clínica
      • Gacetilla Para Participantes N° 1
  • Our Sites
  • Site Resources
    • REPRIEVE Site Newsletters
    • REPRIEVE Retention Toolkit
  • My Matters Blog
  • Contact Us
✕

Participant Newsletter

Screenshot 2022-04-05 161249

Volume 7 | 2022

The 2022 participant newsletter includes a message from REPRIEVE leadership, REPRIEVE facts, heart health tips, a message from the Community Advisory Board, a section on a fellow REPRIEVE participant, and other exciting updates!

English
Spanish
Portuguese
Sesotho
Xhosa
Zulu
Thai
French
French Canadian
Haitian Creole

Participant Newsletter Archive

  • Volume 6 | 2021
  • Volume 5 | 2020
  • Volume 4 | 2019
  • Volume 3 | 2018
  • Volume 2 | 2017
  • Volume 1 | 2016

English

Spanish

Portuguese

Afrikaans

Sesotho

Xhosa

Zulu

Thai

English

Afrikaans

French

Haitian-Creole

Portuguese

Spanish

Xhosa

Zulu

Sesotho

Thai

English

Africaans

Hatian Creole

Español

Français

Portuguesa

Sesotho

Xhosa

Zulu

Africaans

Creole

English

Español

Français

Portuguesa

Xhosa

English

Español

Français

Português

English

Español

For Participants

  • REPRIEVE Community Forum
  • REPRIEVE Community Advisory Board (CAB)
  • Meet REPRIEVE Participants
  • My Heart Matters Blog
  • Participant Newsletter
  • Recursos en Español
    • Preguntas Más Frecuentes
    • Mapa de Centros de Investigación Clínica
    • Gacetilla Para Participantes

Search

✕
 

Recent News

  • INSTI Use Beyond Two Years Not Associated With Greater Weight Gain in Global REPRIEVE Study
    March 20, 2023
  • New insights into how patient factors and COVID-19 infection affect antibody responses in people with HIV
    March 13, 2023
©2019 | This website, and any related materials applies only to REPRIEVE A5332. See list of participating sites here.